IL2 and Crohn disease: Another study found that riboflavin supplementation reduced systemic oxidative stress in Crohn’s disease patients, exerted anti-inflammatory effects (by decreasing C-reactive protein, platelet count, erythrocyte sedimentation rate, and IL-2 levels), and mitigated clinical disease activity as measured by the Harvey-Bradshaw Index (25).